VeriSkin
San Diego, US · Founded 2016 · Delaware corporation
Biotech
Founders & leadership
KH
Kevin HerzbergDirector
JF
John FitzgibbonDirector
ET
Eugene TuDirector
MC
Mirianas ChachisvilisExecutive Officer, Director
CE
Carl EdmanDirector
Reported raises · per SEC filings
Form D private placements▶$682.3KraisedNov 2020 · 22 investors · BiotechnologyRule 506(b)
▶$682.3KraisedNov 2020 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin HerzbergDirector
- John FitzgibbonDirector
- Eugene TuDirector
- Mirianas ChachisvilisExecutive Officer, Director
- Carl EdmanDirector
- Offering amount
- $1.5M
- Amount sold
- $682.3K
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $2.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.9M |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.